Standardization of Measurement of Components of the Fibrinolytic System - Introduction and Current Status

Overview

Journal EJIFCC

Specialty Biochemistry

Date 2019 Jan 17

PMID 30647553

Authors

Jorgen Gram

Cornelis Kluft

Jorgen Jespersen

Affiliations

Soon will be listed here.

Abstract

There is compelling evidence that measurement of analytes of the fibrinolytic system may be helpful for the clinician in a number of situations. Except for measurement of plasma fibrin d-dimer such quantities have not been widespread introduced in the clinical laboratory. One main reason for this is a documented large method and interlaboratory variation for specific analytes. This manuscript describes historical aspects and the current status of standardization with respect to measurement of fibrinolytic quantities. Also, it describes recent initiatives taken within the framework of International Society of Thrombosis and Haemostasis (ISTH) and the International Federation of Clinical Chemistry (IFCC) to promote standardization within the field of fibrinolysis (and coagulation).

References

Collen D, Lijnen H . Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 1991; 78(12):3114-24. View

Gram J, Declerck P, Sidelmann J, Jespersen J, Kluft C . Multicentre evaluation of commercial kit methods: plasminogen activator inhibitor activity. Thromb Haemost. 1993; 70(5):852-7. View

Buttner J . The need for accuracy in laboratory medicine. Eur J Clin Chem Clin Biochem. 1995; 33(12):981-8. View

. WHO Expert Committee on Biological Standardization. Thirty-third report. World Health Organ Tech Rep Ser. 1983; 687:1-184. View

Blomback M, Dybkaer R, Jorgensen K, OLESEN H, Thorsen S . International Society on Thrombosis and Haemostasis (ISTH), and International Union of Pure and Applied Chemistry (IUPAC), Clinical Properties and units in the clinical laboratory sciences. V. Properties and units in thrombosis and haemostasis.... Eur J Clin Chem Clin Biochem. 1995; 33(9):637-60. View

Dati F . Quality management and standardization programs in hemostaseology. J Int Fed Clin Chem. 1996; 8(3):110-6. View

Blomback M, Abildgaard U, van den Besselaar A, Clementson K, Dahlback B, Exner T . Nomenclature of quantities and units in thrombosis and haemostasis (recommendation 1993). A Collaborative project of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH/SSC) and the.... Thromb Haemost. 1994; 71(3):375-94. View

Declerck P, Moreau H, Jespersen J, Gram J, Kluft C . Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1). Thromb Haemost. 1993; 70(5):858-63. View

ASTRUP T . Fibrinolysis in the organism. Blood. 1956; 11(9):781-806. View

10.

Wang W, Boffa M, Bajzar L, Walker J, Nesheim M . A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor. J Biol Chem. 1998; 273(42):27176-81. DOI: 10.1074/jbc.273.42.27176. View

11.

ASTRUP T . The biological significance of fibrinolysis. Lancet. 1956; 271(6942):565-8. DOI: 10.1016/s0140-6736(56)92048-7. View

12.

TIETZ N . A model for a comprehensive measurement system in clinical chemistry. Clin Chem. 1979; 25(6):833-9. View

13.

McQueen M, Roberts H, Siest G . Reference materials and reference measurement systems in laboratory medicine--a major international meeting organized by the International Federation of Clinical Chemistry (IFCC), Geneva, October 5-7, 1994. Eur J Clin Chem Clin Biochem. 1995; 33(12):977-9. View

14.

Gaffney P . Standards in fibrinolysis--current status and future challenges. Thromb Haemost. 1995; 74(6):1389-97. View